English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Dec 17, 2015

FDA approves antidote for muscle relaxants used in breathing tube insertion
+ Technology/Innovation
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
+ Technology/Innovation
Jamie Barrand | Dec 17, 2015

Narcan Nasal Spray approved by FDA for treatment of opioid overdose
+ Technology/Innovation
Jamie Barrand | Dec 17, 2015

AstraZeneca acquires core respiratory business of Takeda Pharmaceuticals
+ Technology/Innovation
Jamie Barrand | Dec 16, 2015

FDA approves first-ever treatment for chemotherapy overdose
+ Technology/Innovation
Jamie Barrand | Dec 16, 2015

Bristol-Myers Squibb, UCLA team up for cancer research
+ Technology/Innovation
Jamie Barrand | Dec 16, 2015

FDA approves new therapy for advanced lung cancer
+ Technology/Innovation
Jamie Barrand | Dec 15, 2015

Bellicum, Astellas Pharma partner on cancer therapy research

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation